Vorapaxar Associated With Reduced Incidence of Stroke vs Placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
New Ischemic Stroke and Outcomes With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial
J Am Coll Cardiol 2014 Dec 09;64(22)2318-2326, MP Bonaca, BM Scirica, E Braunwald, SD Wiviott, S Goto, DW Nilsen, V Bonarjee, SA Murphy, DA MorrowFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.